AJADUO | EMPAGLIFLOZIN + LINAGLIPTIN |  |
BUDAMATE | BUDESONIDE + FORMOTEROL |  |
CETIL | CEFUROXIME AXETIL |  |
CIDMUS | SACUBITRIL + VALSARTAN |  |
CLOPITAB | CLOPIDOGREL BISULFATE |  |
FERINJECT | IRON FERRIC CARBOXYMALTOSE |  |
GIBTULIO | EMPAGLIFLOZIN |  |
GLUCONORM-G | GLIMEPIRIDE + METFORMIN |  |
HUMINSULIN | INSULIN HUMAN BASE RECOMBINANT + INSULIN HUMAN ISOPHANE RECOMBINANT |  |
IVABRAD | IVABRADINE |  |
LUPIHEME | IRON METAL |  |
LUPISULIN-M | INSULIN HUMAN BASE RECOMBINANT + INSULIN HUMAN ISOPHANE RECOMBINANT |  |
MEROTROL | MEROPENEM |  |
ONDERO | LINAGLIPTIN |  |
RABLET | RABEPRAZOLE |  |
SIGNOFLAM | ACECLOFENAC + PARACETAMOL + SERRAPEPTASE |  |
TAZAR | PIPERACILLIN + TAZOBACTAM |  |
TELEKAST-L | LEVOCETIRIZINE + MONTELUKAST |  |
TONACT | ATORVASTATIN |  |
Pingback: USFDA approves Lupin’s Posaconazole tablets > PharmaCampus